| Revue: | Revista de saude publica |
| Base de datos: | |
| Número de sistema: | 000535732 |
| ISSN: | 0034-8910 |
| Autores: | Buehler, Anna Maria1 Dionne, Pierre-Alexandre2 Chandiwana, David2 Pathak, Purnima2 Igho Osagie, Ebuwa3 |
| Instituciones: | 1Novartis Biociências S.A., São Paulo, SP. Brasil 2Novartis Global, East Hanover, NJ. Estados Unidos 3Novartis Global, Business Flagship Programs, East Hanover, NJ. Estados Unidos |
| Año: | 2022 |
| Volumen: | 56 |
| País: | Brasil |
| Idioma: | Inglés |
| Resumen en inglés | OBJETIVE To evaluate the effect of ribociclib versus endocrine therapy on productivity losses due to advanced breast cancer. METHODS Productivity data from the MONALEESA-7 trial, obtained from the results of the application of the Work Productivity and Activity Impairment (WPAI) questionnaire on progression-free survival state (43-month follow-up), were extrapolated to the 10,936 Brazilian prevalent cases of premenopausal women with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) breast cancer. Productivity loss was determined by quantifying the economic costs of workforce dropout over time in both treatment arms and by discounting the economic costs of absenteeism and presenteeism from workforce retention. A human capital approach was used. RESULTS Net productivity gains in the ribociclib arm were estimated at USD 4,285,525.00, representing 316,609 added work hours over 43 months and a mean of 2,009 added work weeks per year. CONCLUSIONS The phase III MONALEESA-7 trial productivity results applied to the Brazilian premenopausal prevalent cases of hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) breast cancer showed that treatment with ribociclib + endocrine therapy improves workforce participation compared with endocrine therapy alone in premenopausal women with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) metastatic breast cancer, with potential economic gains for the Brazilian society. |
| Keyword: | Women, Premenopause, Breast Neoplasms, therapy, Absenteeism, Workforce, economics |
| Texte intégral: | Texto completo (Ver HTML) Texto completo (Ver PDF) |
